LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships14.1.2025 13:21:17 CET | LTS Lohmann Therapie-Systeme AG | Press release
Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies.